21. Neratinib after trastuzumab-based adjuvant therapy in HER2-positive breast cancer (ExteNET): 5-year analysis of a randomised, double-blind, placebo-controlled, phase 3 trial. Issue 12 (December 2017) Authors: Martin, Miguel; Holmes, Frankie A; Ejlertsen, Bent; Delaloge, Suzette; Moy, Beverly; Iwata, Hiroji; von Minckwitz, Gunter; Chia, Stephen K L; Mansi, Janine; Barrios, Carlos H; Gnant, Michael; Tomašević, Zorica; Denduluri, Neelima; Šeparović, Robert; Gokmen, Erhan; Bashford, Anna; Ruiz Borrego, Ma... Journal: Lancet oncology Issue: Volume 18:Issue 12(2017:Dec.) Page Start: 1688 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
22. Neratinib after trastuzumab-based adjuvant therapy in patients with HER2-positive breast cancer (ExteNET): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial. Issue 3 (March 2016) Authors: Chan, Arlene; Delaloge, Suzette; Holmes, Frankie A; Moy, Beverly; Iwata, Hiroji; Harvey, Vernon J; Robert, Nicholas J; Silovski, Tajana; Gokmen, Erhan; von Minckwitz, Gunter; Ejlertsen, Bent; Chia, Stephen K L; Mansi, Janine; Barrios, Carlos H; Gnant, Michael; Buyse, Marc; Gore, Ira; Smith, John;... Journal: Lancet oncology Issue: Volume 17:Issue 3(2016:Mar.) Page Start: 367 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
23. Net benefit in the presence of correlated prioritized outcomes using generalized pairwise comparisons: A simulation study. (2nd November 2020) Authors: Giai, Joris; Maucort‐Boulch, Delphine; Ozenne, Brice; Chiêm, Jean‐Christophe; Buyse, Marc; Péron, Julien Journal: Statistics in medicine Issue: Volume 40:Number 3(2021) Page Start: 553 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
24. On the relationship between the causal‐inference and meta‐analytic paradigms for the validation of surrogate endpoints. Issue 1 (1st October 2014) Authors: Alonso, Ariel; Van der Elst, Wim; Molenberghs, Geert; Buyse, Marc; Burzykowski, Tomasz Journal: Biometrics Issue: Volume 71:Issue 1(2015) Page Start: 15 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
25. On the use of extreme value tail modeling for generalized pairwise comparisons with censored outcomes. (2nd November 2022) Authors: De Backer, Mickaël; Legrand, Catherine; Péron, Julien; Lambert, Alexandre; Buyse, Marc Journal: Pharmaceutical statistics Issue: Volume 22:Number 2(2023) Page Start: 284 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
26. Open science: The open clinical trials data journey. (October 2019) Authors: Rockhold, Frank; Bromley, Christina; Wagner, Erin K; Buyse, Marc Journal: Clinical trials Issue: Volume 16:Number 5(2019) Page Start: 539 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
27. Outcome measures in multimodal rectal cancer trials. Issue 5 (May 2020) Authors: Fokas, Emmanouil; Glynne-Jones, Robert; Appelt, Ane; Beets-Tan, Regina; Beets, Geerard; Haustermans, Karin; Marijnen, Corrie; Minsky, Bruce D; Ludmir, Ethan; Quirke, Phil; Sebag-Montefiore, David; Garcia-Aguilar, Julio; Gambacorta, Maria Antonietta; Valentini, Vincenzo; Buyse, Marc; Rödel, Claus Journal: Lancet oncology Issue: Volume 21:Issue 5(2020) Page Start: e252 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
28. Overall survival with neratinib after trastuzumab-based adjuvant therapy in HER2-positive breast cancer (ExteNET): A randomised, double-blind, placebo-controlled, phase 3 trial. (May 2023) Authors: Holmes, Frankie A.; Moy, Beverly; Delaloge, Suzette; Chia, Stephen K.L.; Ejlertsen, Bent; Mansi, Janine; Iwata, Hiroji; Gnant, Michael; Buyse, Marc; Barrios, Carlos H.; Silovski, Tajana; Šeparović, Robert; Bashford, Anna; Zotano, Angel Guerrero; Denduluri, Neelima; Patt, Debra; Gokmen, Erhan; Gor... Journal: European journal of cancer Issue: Volume 184(2023) Page Start: 48 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
29. Prediction of survival benefits from progression-free survival benefits in advanced non-small-cell lung cancer: evidence from a meta-analysis of 2334 patients from 5 randomised trials. Issue 3 (13th March 2013) Authors: Laporte, Silvy; Squifflet, Pierre; Baroux, Noémie; Fossella, Frank; Georgoulias, Vassilis; Pujol, Jean-Louis; Douillard, Jean-Yves; Kudoh, Shinzohy; Pignon, Jean-Pierre; Quinaux, Emmanuel; Buyse, Marc Journal: BMJ open Issue: Volume 3:Issue 3(2013) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
30. Professor Maurice Staquet, MD, MS (1930 – 2013). (31st October 2013) Authors: Duez, Nicole; Eeckhoudt, Dominique; Kirkpatrick, Anne; Solbu, Gabriel; Suciu, Stefan; Sylvester, Richard; Van Glabbeke, Martine; Buyse, Marc; Dalesio, Otilia; Renard, Josette; Rotmensz, Nicole; Aalen, Odd O.; Borgan, Ørnulf; Kvaløy, Jan Terje Journal: Statistics in medicine Issue: Volume 32:Number 30(2013) Page Start: 5219 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗